Article Text
Abstract
The West African Ebola epidemic has set in motion a collective endeavour to conduct accelerated clinical trials, testing unproven but potentially lifesaving interventions in the course of a major public health crisis. This unprecedented effort was supported by the recommendations of an ad hoc ethics panel convened in August 2014 by the WHO. By considering why and on what conditions the exceptional circumstances of the Ebola epidemic justified the use of unproven interventions, the panel's recommendations have challenged conventional thinking about therapeutic development and clinical research ethics. At the same time, unanswered ethical questions have emerged, in particular: (i) the specification of exceptional circumstances, (ii) the specification of unproven interventions, (iii) the goals of interventional research in terms of individual versus collective interests, (iv) the place of adaptive trial designs and (v) the exact meaning of compassionate use with unapproved interventions. Examination of these questions, in parallel with empirical data from research sites, will help build pragmatic foundations for disaster research ethics. Furthermore, the Ebola clinical trials signal an evolution in the current paradigms of therapeutic research, beyond the case of epidemic emergencies.
- Public Health Ethics
- Research Ethics
- Clinical trials
- Autonomy
- NGOs
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Other content recommended for you
- Accessing unproven interventions in the COVID-19 pandemic: discussion on the ethics of ‘compassionate therapies’ in times of catastrophic pandemics
- Aspects of disaster research ethics applicable to other contexts
- If it walks like a duck…: Monitored Emergency Use of Unregistered and Experimental Interventions (MEURI) is research
- Vaccine testing for emerging infections: the case for individual randomisation
- Forty-two years of responding to Ebola virus outbreaks in Sub-Saharan Africa: a review
- Ebola, viewed through a lens of African epidemiology
- The cost of public health interventions to respond to the 10th Ebola outbreak in the Democratic Republic of the Congo
- Cross-sectional study of mental health and sexual behaviours for Ebola Survivors in Beni, Butembo and Katwa health zones of the Democratic Republic of Congo
- Ebola: what it teaches us about medical ethics. A response to Angus Dawson
- WHO guidance on ethics in outbreaks and the COVID-19 pandemic: a critical appraisal